Press release
In-Depth Analysis of the VariZIG Market: Growth Opportunities, Key Trends, and Forecast 2025-2034
VariZIGMarket Size
The increase in varicella-zoster virus (VZV) infections is expected to accelerate the growth of the Varizig market. VZV is a contagious virus that causes chickenpox initially and can reactivate later as shingles. The rise in VZV infections is attributed to reduced vaccination rates, aging populations, and immune suppression from medical treatments. Varizig helps by offering passive immunity, alleviating the severity and duration of chickenpox, preventing complications in high-risk individuals, and protecting neonates and pregnant women exposed to the virus. In November 2024, the Florida Department of Health reported an increase in varicella cases to 653 in 2023, up from 428 in 2022. Therefore, the rise in VZV infections is driving the Varizig market.
Get Your VariZIG Market Report Here:
https://www.thebusinessresearchcompany.com/report/varizig-global-market-report
What is the projected compound annual growth rate (CAGR) of the varizig market from 2025 to 2034, and what factors influence it?
The Varizig market size has shown XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025, at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rise in healthcare expenditure, an increase in organ transplantation procedures, more government funding for immunization programs, the growing geriatric population, and the rise in private insurance coverage.
The Varizig market is expected to reach $XX million by 2029, growing at a CAGR of XX%. This growth is due to the increasing incidence of chickenpox, rising investment in varicella-related biologics, and growing demand for immune globulin products. Trends include advancements in recombinant DNA technology, development of novel formulations, and the adoption of telemedicine.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20448&type=smp
How are the latest trends influencing the growth of the varizig market?
The dominant trend in the varizig market includes making supply agreement deals to the product targeting high-risk patient group, broadening distribution avenues, and fulfilling the increasing requirement for passive immunization, especially in urgent and high-risk situations. Typically, supply agreements describe the terms and conditions of supplying goods or services and include details such as pricing, delivery timelines, and obligations of each involved party. For example, in July 2022, an organization primarily operating in Latin America and Kamada Ltd, a biopharmaceutical company based in Israel, entered into a procurement agreement worth $11.4 million to supply varizig. The supplies are projected to occur from the last quarter of 2022 to the first half of 2023. This agreement underlines Kamada's strategy of escalating its sales of FDA-approved plasma-derived therapies on a global scale, indicating its commercial possibilities outside North America. Specifically, VARIZIG is used for post-exposure prophylaxis of varicella (chickenpox) among high-risk groups such as immunocompromised patients and newborns, identifying it as a vital therapeutic choice for these groups.
What are the major segments of the varizig market and their role in driving growth?
The varizig market covered in this report is segmented -
1) By Patient Condition: Immunocompromised Patients; Pregnant Women
2) By Distribution Channel: Hospitals; Pharmacies; Healthcare Providers
3) By End User: Adult; Geriatric; Pediatric
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20448
Which regions are key players in the growth of the varizig market?
North America was the largest region in the varizig market in 2024. The regions covered in the varizig market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the varizig market?
Major companies operating in the varizig market are Emergent BioSolutions Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20448&type=smp
What Is Covered In The VariZIG Global Market Report?
•Market Size Forecast: Examine the varizig market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the varizig market for a structured understanding.
•Key Players Overview: Analyze major players in the varizig market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the varizig market.
•Segment Contributions: Evaluate how different segments drive overall growth in the varizig market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the varizig market.
•Industry Challenges: Identify potential risks and obstacles affecting the varizig market.
•Competitive Landscape: Review strategic developments in the varizig market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-Depth Analysis of the VariZIG Market: Growth Opportunities, Key Trends, and Forecast 2025-2034 here
News-ID: 3944619 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for VariZIG
VariZIG Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportuniti …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the VariZIG Market?
In recent times, the varizig market size has seen an increase of XX (HCAGR). Over the course of a year, from 2024 to 2025, the market is projected to expand from $XX million to $XX million, recording a compound annual growth rate (CAGR)…
What's Driving the VariZIG Market 2025-2034: Rising Incidence Of Varicella-Zoste …
What Are the Projections for the Size and Growth Rate of the VariZIG Market?
In recent times, the varizig market has experienced a $XX (CAGR). We can anticipate its growth from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of $XX%. The expansion during the historical period can be credited to an increase in health care spending, a surge in organ transplantation procedures,…
